Search company, investor...

Stage

Other Investors | Alive

About Pro-Duct Health

Pro-Duct Health is a medical device company focused on developing and commercializing products for non-invasive detection of breast cancer.

Headquarters Location

Menlo Park, California, 94025,

United States

Loading...

Loading...

Pro-Duct Health Frequently Asked Questions (FAQ)

  • Where is Pro-Duct Health's headquarters?

    Pro-Duct Health's headquarters is located at Menlo Park.

  • What is Pro-Duct Health's latest funding round?

    Pro-Duct Health's latest funding round is Other Investors.

  • Who are the investors of Pro-Duct Health?

    Investors of Pro-Duct Health include Montreux Equity Partners.

  • Who are Pro-Duct Health's competitors?

    Competitors of Pro-Duct Health include Cyberheart, Avantis Medical Systems, Myomo, DIRAmed, SenoRx and 7 more.

Loading...

Compare Pro-Duct Health to Competitors

B
Biopsys Medical

News of a breast biopsy raises many emotions and concerns. The company understand. But it's important to remember that 80% of breast biopsies do not turn out to be breast cancer. It's also important to know that users have options when selecting a biopsy procedure. This site is dedicated to evaluating their choices to help users talk with their doctor about the breast biopsy procedure that is right for users. One of those choices is a minimally invasive breast biopsy for breast cancer diagnosis using the Mammotome Breast Biopsy System. Mammotome is made available by Ethicon Endo-Surgery, Inc.

P
PreMD

PreMD Inc. is dedicated to saving and improving people's lives with simple, painless and patient-friendly tests that can detect life-threatening illnesses at a. The company's tests do not require any patient preparation or dietary restrictions and can be performed at the point of care, in a laboratory setting and, in some cases, even at home. The company's cardiovascular risk assessment technology, PREVU* Skin Sterol Test, assesses a patient's risk of heart disease by non-invasively measuring the amount of cholesterol in the skin tissues. PreMD's non- or minimally-invasive tests for early-stage colorectal, lung and breast cancers detect a cancer-associated sugar in a sample of rectal mucus, sputum and breast nipple aspirate fluid, respectively. The company's cancer tests are in development.

R
RadioTherapeutics

RadioTherapeutics Corporation is developing tools for minimally invasive treatment of solid tumors. The RF 2000B is used by surgeons, interventional radiologists, and gastroenterologists to predictably, precisely and homogeneously ablate diseased or unwanted volumes of soft tissues.

Monteris Medical Logo
Monteris Medical

Monteris Medical is a neurosurgical company that operates in the healthcare industry. The company offers a minimally invasive, robotically controlled laser thermal therapy system that uses MRI-guided laser light to destroy unwanted tissue in the brain, such as tumors and lesions. Monteris primarily serves the healthcare sector, particularly neurosurgery. It was founded in 1999 and is based in Hopkins, Minnesota.

W
Windy Hill Medical

Windy Hill Medical is a medical device and pharmaceutical company focused on the development of products to reduce the risk of developing breast cancer in patients deemed to be at high risk.

O
OrSense

OrSense is a medical device company that focuses on the development and marketing of non-invasive monitoring systems within the healthcare industry. The company's main products are systems that measure Hemoglobin levels in a non-invasive manner, providing a user-friendly and safe method for anemia testing and blood analyte monitoring. These products primarily cater to the healthcare sector, particularly in blood donation facilities. It is based in Israel.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.